CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $716,682
- in 3 filings
Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-18 | Stergiou Angelos M. President and CEO | Sale | −26,606 | $19.18 | $510K | 1,734,896 |
| 2026-06-16 | Stergiou Angelos M. President and CEO | Grant or award | +1,065,000 | 1,759,183 | ||
| 2025-12-03 | Stergiou Angelos M. President and CEO | Other disposition | −187,066 | $1.50 | $281K | 686,966 |
| 2025-01-10 | Stergiou Angelos M. President and CEO | Grant or award | +257,000 | 615,132 | ||
| 2025-01-10 | Stergiou Angelos M. President and CEO | Grant or award | +243,900 | 859,032 | ||
| 2025-01-10 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +385,750 | 385,750 | ||
| 2024-12-04 | Stergiou Angelos M. President and CEO | Other disposition | −28,289 | $1.13 | $32K | 358,132 |
| 2024-01-22 | Stergiou Angelos M. President and CEO | Grant or award | +159,000 | 376,421 | ||
| 2024-01-22 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +238,500 | 238,500 | ||
| 2023-12-06 | Stergiou Angelos M. President and CEO | Other disposition | −12,268 | $1.08 | $13K | 217,421 |
| 2023-02-02 | Stergiou Angelos M. President and CEO | Grant or award | +58,000 | 219,689 | ||
| 2023-02-02 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +217,500 | 217,500 | ||
| 2022-12-05 | Stergiou Angelos M. President and CEO | Sale | −6,494 | $2.61 | $17K | 161,689 |
| 2022-01-31 | Stergiou Angelos M. President and CEO | Grant or award | +44,000 | 165,167 | ||
| 2022-01-31 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2021-12-02 | Stergiou Angelos M. President and CEO | Sale | −2,120 | $6.25 | $13K | 121,167 |
| 2021-03-04 | Stergiou Angelos M. President and CEO | Grant or award | +19,750 | 98,287 | ||
| 2021-03-04 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +118,500 | 118,500 | ||
| 2020-03-12 | Stergiou Angelos M. President and CEO | Grant or award | +95,000 | 95,000 | ||
| 2020-03-12 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 |
Page 1 of 2 · 23 trades